甲泼尼龙琥珀酸钠对重症支原体肺炎患儿症状消失时间及炎症反应的影响

doi:10.3969/j.issn.1000-8535.2024.01.009

摘要/Abstract

摘要： 目的研究甲泼尼龙琥珀酸钠对重症支原体肺炎（SMPP）患儿的治疗效果及安全性。方法采用随机数表法将南华大学附属长沙中心医院2021年1月—2022年12月收治的108例SMPP患儿分为两组,对照组（54例）采用常规治疗,研究组（54例）采用常规治疗联合甲泼尼龙琥珀酸钠治疗,比较2组临床疗效。结果治疗后研究组炎症因子水平低于对照组,肺功能指标、健康状况评分均高于对照组,发热、咳嗽、肺啰音及肺阴影消失时间均短于对照组（P<0.05）;两组不良反应发生率比较差异无统计学意义（P>0.05）。结论应用甲泼尼龙琥珀酸钠治疗可加快患儿症状缓解,改善机体炎症反应及肺功能,且安全性较高。

关键词: 重症支原体肺炎, 甲泼尼龙琥珀酸钠, 炎症反应

Abstract: Objective To study the therapeutic effect and safety of methylprednisolone sodium succinate on children with severe Mycoplasma pneumoniae pneumonia（SMPP）．Methods A total of 108 children with SMPP admitted to Changsha Central Hospital from January 2021 to December 2022 were divided into two groups by random number table method．The control group（54 cases）was treated with conventional therapy,and the study group（54 cases）was treated with conventional therapy combined with methylprednisolone sodium succinate．The clinical effects of the two groups were compared．Results After treatment,the levels of inflammatory factors in the study group were lower than those in the control group,and lung function indicators and health status scores were higher than those in the control group．The disappearance time of fever,cough,lung rales and lung shadows was shorter than that in the control group（P<0.05）．There was no statistically significant difference in the incidence of adverse reactions between the two groups（P>0.05）．Conclusions The application of methylprednisolone sodium succinate treatment can accelerate the relief of symptoms in children,improve the body's inflammatory response and lung function,and has high safety．

Key words: severe Mycoplasma pneumoniae pneumonia, methylprednisolone sodium succinate, inflammatory reaction

王颖. 甲泼尼龙琥珀酸钠对重症支原体肺炎患儿症状消失时间及炎症反应的影响[J]. 广州医药, 2024, 55(1): 54-58.

WANG Ying. Effect of methylprednisolone sodium succinate on the time of symptom disappearance and inflammatory reaction in children with severe Mycoplasma pneumoniae pneumonia[J]. Guangzhou Medical Journal, 2024, 55(1): 54-58.

参考文献

[1] 胡高声,王夏林,蔡欣欣.常规剂量甲泼尼龙联合吸入型糖皮质激素治疗儿童难治性肺炎支原体肺炎的疗效[J].儿科药学杂志,2020,26(12):25-29.
[2] 曹美琴. 小剂量注射用甲泼尼龙琥珀酸钠联合阿奇霉素治疗肺炎支原体肺炎患儿的疗效评价[J].中国药物与临床,2020,20(16):2743-2745.
[3] 中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[4] 蔚变霞. 甲泼尼龙琥珀酸钠联合阿奇霉素治疗小儿重症支原体肺炎疗效及其对免疫功能的影响[J].中国基层医药,2020,27(3):331-334.
[5] 张贺,刘晓萌,宋义琴,等.甲泼尼龙辅助治疗儿童肺炎支原体感染性大叶性肺炎疗效与安全性分析[J].新医学,2020,51(8):624-627.
[6] 李艳. 支原体肺炎患儿经匹多莫德、甲泼尼龙琥珀酸钠联合阿奇霉素治疗对其免疫功能及临床疗效的影响研究[J].贵州医药,2022,46(6):918-919.
[7] 吴英,郭丽敏,杨琴,等.不同剂量甲泼尼龙琥珀酸钠联合阿奇霉素治疗儿童难治性肺炎支原体肺炎的疗效观察[J].国际儿科学杂志,2021,48(6):420-425.
[8] 徐树香,侯培华.甲泼尼龙琥珀酸钠联合阿奇霉素治疗小儿重症支原体肺炎的疗效及其对免疫功能的影响[J].世界复合医学,2021,7(7):188-190.
[9] 袁巧云. 注射用甲泼尼龙琥珀酸钠联合阿奇霉素对儿童支原体大叶性肺炎症状改善及血清炎性因子水平的影响[J].中国药物与临床,2021,21(24):4041-4043.
[10] 陈海丹,张华.丙种球蛋白联合甲泼尼龙治疗小儿重症支原体肺炎的疗效及对免疫功能、肺功能的影响[J].医学综述,2021,27(17):3525-3530.
[11] 王子威,胡彦宏,何瑜娜,等.纤维支气管镜肺泡灌洗与甲泼尼龙治疗难治性肺炎支原体肺炎的疗效比较[J].北京医学,2021,43(2):126-129.
[12] 汪珊,韦红,李启先.甲泼尼龙琥珀酸钠治疗儿童重症支原体肺炎的疗效及对炎症因子的影响[J].蚌埠医学院学报,2022,47(1):44-46.
[13] 陈玲,胡荆江,覃军.低剂量甲泼尼龙琥珀酸钠对重症支原体肺炎患儿T淋巴细胞亚群及炎症因子水平的影响[J].中国现代医学杂志,2023,33(5):63-67.
[14] 刘晓萌,张燕北,于海明,等.甲泼尼龙琥珀酸钠治疗儿童重症支原体肺炎的效果及对炎症因子的影响[J].中国医药导报,2021,18(29):98-101.
[15] 聂晓伟. 阿奇霉素联合甲泼尼龙治疗小儿重症支原体肺炎对免疫功能的影响[J].宁夏医科大学学报,2021,43(7):697-701.
[16] 原艳敏. 不同剂量甲泼尼龙对小儿重症支原体肺炎的疗效、症状恢复时间的影响[J].贵州医药,2020,44(9):1382-1383.
[17] 赵梦娇,王玺.阿奇霉素联合甲泼尼龙治疗小儿肺炎支原体肺炎的效果及胸部CT征象变化[J].影像科学与光化学,2022,40(6):1550-1554.
[18] 陈颖,姜洁,王娜娜.炎琥宁联合甲泼尼龙治疗迁延性肺炎支原体肺炎的效果及对气道炎性反应的影响[J].中国医药,2020,15(12):1874-1877.
[19] 刘雪莲,李文联.金振口服液联合甲泼尼龙治疗儿童难治性肺炎支原体肺炎临床疗效及对肺功能的影响[J].湖北中医药大学学报,2022,24(2):27-30.
[20] 胡彩云,姜家利,徐卫华,等.甲泼尼龙联合肺泡灌洗治疗肺炎支原体肺炎的效果及对患儿乳酸脱氢酶和高敏C反应蛋白水平的影响[J].中国医药,2021,16(5):680-683.